Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of caffeine on people suffering from intermittent claudication
2006-001902-10Phase 3Completed
- Sponsor
- Kirurgisk Forskningsafsnit, Herning Sygehus
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of caffeine in arteriosclerosis obliterans and intermittent claudication (IC), sponsored by Kirurgisk Forskningsafsnit, Herning Sygehus. Primary endpoint: Maximum Walking Distance. Started May 2006; status: completed.
02
Drugs
caffeine
03
Conditions
arteriosclerosis obliteransintermittent claudication (IC)
Beyond the preview
Go deeper on 2006-001902-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001902-10.